Search research articles
Contact Us
Filters
Showing results (81-90 of 181) with videos related to
Page
of 19
Sort By:
Cancer Chemotherapy and Pharmacology
|
September 30, 2016
Randomized phase 1 crossover study assessing the bioequivalence of capsule and tablet formulations of dovitinib (TKI258) in patients with advanced solid tumors
John Sarantopoulos, Sanjay Goel, Vincent Chung, et al.
Annals of Surgery
|
January 3, 2020
Postoperative Chemotherapy Benefits Patients Who Received Preoperative Therapy and Pancreatectomy for Pancreatic Adenocarcinoma
Giampaolo Perri, Laura Prakash, Wei Qiao, et al.
The Oncologist
|
March 26, 2025
A phase I/II trial of avelumab combinations with ivuxolimab, utomilumab, and radiation therapy in patients with advanced gastrointestinal malignancies
Jibran Ahmed, Anne Knisely, Carlos Torrado, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2025
HER2-Positivity as a Prognostic Biomarker and Therapeutic Target in Advanced Biliary Tract Cancer: A Multi-Institutional Analysis
Sunyoung S Lee, Dong Hyun Seo, Taek Chung, et al.
British Journal of Haematology
|
October 14, 2009
Incidence and reasons for late failure after allogeneic haematopoietic cell transplantation following BuCy2 in acute myeloid leukaemia
Shubham Pant, Mehdi Hamadani, Anthony J Dodds, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 26, 2019
Corrigendum to "Predicting outcomes in patients with advanced non-small cell lung cancer enrolled in early phase immunotherapy trials" [Lung Cancer 120 (June) (2018) 137-141]
Hossein Maymani, Kenneth Hess, Roman Groisberg, et al.
JAMA Surgery
|
July 16, 2020
Response and Survival Associated With First-line FOLFIRINOX vs Gemcitabine and nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma
Giampaolo Perri, Laura Prakash, Wei Qiao, et al.
Cancer Chemotherapy and Pharmacology
|
June 26, 2012
Phase I/II trial of non-cytotoxic suramin in combination with weekly paclitaxel in metastatic breast cancer treated with prior taxanes
Maryam B Lustberg, Shubham Pant, Amy S Ruppert, et al.
Targeted Oncology
|
September 24, 2021
A Phase 1b Trial of Prexasertib in Combination with Standard-of-Care Agents in Advanced or Metastatic Cancer
Kathleen N Moore, David S Hong, Manish R Patel, et al.
Eclinicalmedicine
|
April 19, 2021
First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors
Gerald Falchook, Jeffrey Infante, Hendrik-Tobias Arkenau, et al.
Page
of 19
Search research articles
Search
Showing results (81-90 of 181) with videos related to
Sort By:
Page
of 19
Cancer Chemotherapy and Pharmacology
|
September 30, 2016
Randomized phase 1 crossover study assessing the bioequivalence of capsule and tablet formulations of dovitinib (TKI258) in patients with advanced solid tumors
John Sarantopoulos, Sanjay Goel, Vincent Chung, et al.
Annals of Surgery
|
January 3, 2020
Postoperative Chemotherapy Benefits Patients Who Received Preoperative Therapy and Pancreatectomy for Pancreatic Adenocarcinoma
Giampaolo Perri, Laura Prakash, Wei Qiao, et al.
The Oncologist
|
March 26, 2025
A phase I/II trial of avelumab combinations with ivuxolimab, utomilumab, and radiation therapy in patients with advanced gastrointestinal malignancies
Jibran Ahmed, Anne Knisely, Carlos Torrado, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2025
HER2-Positivity as a Prognostic Biomarker and Therapeutic Target in Advanced Biliary Tract Cancer: A Multi-Institutional Analysis
Sunyoung S Lee, Dong Hyun Seo, Taek Chung, et al.
British Journal of Haematology
|
October 14, 2009
Incidence and reasons for late failure after allogeneic haematopoietic cell transplantation following BuCy2 in acute myeloid leukaemia
Shubham Pant, Mehdi Hamadani, Anthony J Dodds, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 26, 2019
Corrigendum to "Predicting outcomes in patients with advanced non-small cell lung cancer enrolled in early phase immunotherapy trials" [Lung Cancer 120 (June) (2018) 137-141]
Hossein Maymani, Kenneth Hess, Roman Groisberg, et al.
JAMA Surgery
|
July 16, 2020
Response and Survival Associated With First-line FOLFIRINOX vs Gemcitabine and nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma
Giampaolo Perri, Laura Prakash, Wei Qiao, et al.
Cancer Chemotherapy and Pharmacology
|
June 26, 2012
Phase I/II trial of non-cytotoxic suramin in combination with weekly paclitaxel in metastatic breast cancer treated with prior taxanes
Maryam B Lustberg, Shubham Pant, Amy S Ruppert, et al.
Targeted Oncology
|
September 24, 2021
A Phase 1b Trial of Prexasertib in Combination with Standard-of-Care Agents in Advanced or Metastatic Cancer
Kathleen N Moore, David S Hong, Manish R Patel, et al.
Eclinicalmedicine
|
April 19, 2021
First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors
Gerald Falchook, Jeffrey Infante, Hendrik-Tobias Arkenau, et al.
Page
of 19